Inhibition of Mycobacterium tuberculosis secretory serine protease blocks bacterial multiplication both in axenic culture and in human macrophages

References

• Chaparas SD. Immunity in tuberculosis. Bull W H O 1982; 4: 447–62
   Google Scholar
• Deirdre MK, Annemieke MB, Seonadh MO, Mary PO, Joseph K. Bystander mcrophage apoptosis after Mycobacterium tuberculosis H37Ra infection. Infect Immun 2008; 76: 351–60
   PubMedGoogle Scholar
• Maeda H. Role of microbial proteases in pathogenesis. Microbiol Immunol 1996; 40: 685–99
   PubMed Web of Science ®Google Scholar
• Nair, ER, Banerjee, S, Gupta, S, Kumar, S, Reddy, MVR, Harinath, BC. Seroreactivity and characterization of 31 kDa M.tb. secretory protease of diagnostic interest in tuberculosis. Trends Clin Biochem Lab Med 2003;330–8.
   Google Scholar
• Shende N, Gupta S, Bhatia AS, Kumar S, Harinath BC. Detection of free and immune-complexed serine protease and its antibody in TB patients with and without HIV coinfection. Int J Tuberc Lung Dis 2005; 9: 915–9
   PubMedGoogle Scholar
• Miyagawa S, Nishino N, Kamata R, Okamura R, Maeda H. Effects of protease inhibitors on growth of Serratia marcescens and Pseudomonas aeruginosa. Microb Pathog 1991; 11: 137–41
   PubMedGoogle Scholar
• Travis J, Potempa J, Maeda H. Are bacterial proteinases pathogenic factors?. Trends Microbiol 1995; 3: 405–7
   PubMed Web of Science ®Google Scholar
• Pramanik J, Lodam AN, Reddy MVR, Narang P, Harinath BC. Increased yield of excretory secretory antigen with thyroxine supplement in in vitro culture of tubercle bacilli. Ind J Tub 1997; 44: 185–90
   Google Scholar
• Nair ER, Banerjee S, Kumar S, Reddy MVR, Harinath BC. Purification and characterization of a 31 kDa mycobacterial excretory-secretory antigenic protein with a diagnostic potential in pulmonary tuberculosis. Ind J Chest Dis Allied Sci 2001; 43: 81–90
   PubMedGoogle Scholar
• Harinath BC, Kumar S, Saha-Roy S, Hirudkar S, Upadhye V, Shende N. A cocktail of affinity-purified antibodies reactive with diagnostically useful mycobacterial antigens ES-31, ES-43 and EST-6 for detecting the presence of Mycobacterium tuberculosis. Diagn Microbiol Infect Dis 2006; 55: 65–9
   PubMedGoogle Scholar
• Nair ER, Banerjee S, Kumar S, Reddy MVR, Harinath BC. Isolation of Mycobacterium tuberculosis 31 kDa antigen protein of diagnostic interest from culture filtrate using anti-ES-31 antibody by affinity chromatography. Indian J Clin Biochem 2001; 16: 132–5
   PubMedGoogle Scholar
• Upadhye V, Gomashe A, Kumar S, Harinath BC. Isolation, characterization and kinetic studies on SEVA TB ES-31 antigen, a metalloserine protease of interest in diagnosis. Indian J Tuberc 2009; 56: 22–9
   PubMedGoogle Scholar
• Palomino, JC, Leão, SC, Ritacco, V. Tuberculosis 2007: From Basic Science to Patient Care. 1stChapter drug resistance and drug resistance detection, 642.
   Google Scholar
• Beggs W, Jenne J. Growth inhibition of Mycobacterium tuberculosis after single-pulsed exposures to streptomycin, ethambutol and rifampicin. Infect Immun 1970; 2: 479–83
   PubMedGoogle Scholar
• Majumdar A, Upadhye V, Harinath BC. Peroxidase enzyme immunoassay for circulating SEVA TB ES-31 antigen in pulmonary tuberculosis sera. Biomedical Research 2008; 19: 201–6
   Google Scholar
• Zhang M, Gong J, Lin Y, Barnes P. Growth of virulent and avirulent Mycobacterium tuberculosis strain in human macrophages. Infect Immun 1998; 66: 794–9
   PubMed Web of Science ®Google Scholar
• Belisle JT, Vissa VD, Sievert K, Takayama K, Brennan P, Besra GS. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 1997; 276: 1420–2
   PubMed Web of Science ®Google Scholar
• Laal S, Samanich KM, Sonnenberg MG, Zolla-Pazner S, Phadtare JM, Belisle JT. Human humoral responses to antigens of Mycobacterium tuberculosis: immunodominance of high-molecular-mass antigens. Clin Diagn Lab Immunol 1997; 4: 49–56
   PubMedGoogle Scholar
• Nair ER, Banerjee S, Kumar S, Harinath BC. Isolation and characterization of a 31 kDa mycobacterial antigen from tuberculous sera and its identification with in vitro released culture filtrate antigen of M. tb. H37Ra bacilli. Scand J Infect Dis 2000; 32: 551–6
   PubMedGoogle Scholar
• Brown GD, Dave JA, Gey van Pittius NC, Stevens L, Ehlers MRW, Beyers AD. The mycosins of Mycobacterium tuberculosis H37Rv: a family of subtilisin-like serine proteases. Gene 2000; 254: 147–55
   PubMedGoogle Scholar
• Dave JA, Pittius NCG, Beyers AD, Ehlers MRW, Brown GD. Mycosin-1, a subtilisin-like serine protease of Mycobacterium tuberculosis, is cell wall-associated and expressed during infection of macrophages. BMC Microbiol 2002; 2: 1–8
   PubMedGoogle Scholar
• Harth G, Horwitz MA. An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets. J Exp Med 1999; 189: 1425–35
   PubMed Web of Science ®Google Scholar
• Andersen P, Askgaard D, Ljungqvist L, Bennedsen J, Heron I. Proteins released from Mycobacterium tuberculosis during growth. Infect Immun 1991; 59: 1905–10
   PubMed Web of Science ®Google Scholar
• Lind A, Norlin M, Ouchterlony O. Studies on the precipitinogenic pattern of mycobacteria cultivated at various temperatures. Pneumologie 1970; 142: 283–9
   Google Scholar
• Marrakchi H, Laneelle G, Quemard A. InhA, a target of the anti-tuberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II. Microbiology 2000; 146: 289–96
   PubMed Web of Science ®Google Scholar